Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00932191 · ClinicalTrials.gov registry record · Phase 2
Endothelial Cell Loss After Cataract Surgery
A Phase 2 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 2
- Development phase
- 39
- Enrollment target
NCT00932191 is a Phase 2 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 39 participants.
The verdict
NCT00932191, a Phase 2 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two cataract surgical technique variations for removing the nucleus of the lens (central part of the lens) in terms of damage to the inner layer of the cornea which is called the endothelium. One variation uses more ultrasound energy and the other more mechanical force to break up the nucleus.
Interventions
- PROCEDURE Standard phacoemulsification
- PROCEDURE Reduced ultrasound phacoemulsification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00932191
The ClinicalTrials.gov registry entry for NCT00932191 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard phacoemulsification is the first listed.
NCT00932191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00932191 about?
NCT00932191 is a clinical study titled "Endothelial Cell Loss After Cataract Surgery". The purpose of this study is to compare two cataract surgical technique variations for removing the nucleus of the lens (central part of the lens) in terms of damage to the inner layer of the cornea which is called the endothelium. One variation uses more ultrasound energy and the other more mechani...
What is the current status of trial NCT00932191?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 39 participants. The study started on 2009-07. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00932191?
The interventions under investigation include: Standard phacoemulsification (PROCEDURE), Reduced ultrasound phacoemulsification (PROCEDURE).
Who is sponsoring clinical trial NCT00932191?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.